FDA is ramping up requirements for COVID-19 tests amid a surge of variants, despite calls from some public health experts to deregulate rapid at-home tests in order to bring more products to market and help slow asymptomatic spread of the disease. According to some experts, the tests should be categorized as public health tools and shifted to Centers for Disease Control and Prevention oversight, but FDA says it plans to continue to regulate the tests and even recently enhanced requirements...